BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8030105)

  • 1. Triple-drug immunosuppression significantly reduces chronic rejection in noninfected and RCMV-infected rats.
    Lemström K; Bruning J; Koskinen P; Bruggeman C; Lautenschlager I; Häyry P
    Transplant Proc; 1994 Jun; 26(3):1727-8. PubMed ID: 8030105
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
    Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
    Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of leflunomide and cyclosporine on aortic allograft chronic rejection in the rat.
    MacDonald AS; Sabr K; MacAuley MA; McAlister VC; Bitter-Suermann H; Lee T
    Transplant Proc; 1994 Dec; 26(6):3244-5. PubMed ID: 7998130
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of immunosuppression on chronic rejection in the rat aortic allograft model.
    Belitsky P; Gulanikar A; He G; Gupta R
    Transplant Proc; 1993 Feb; 25(1 Pt 2):935. PubMed ID: 8442272
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic rejection of rat aortic allograft. II. Administration of cyclosporin induces accelerated allograft arteriosclerosis.
    Mennander A; Tiisala S; Paavonen T; Halttunen J; Häyry P
    Transpl Int; 1991 Sep; 4(3):173-9. PubMed ID: 1958283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of anti-CD4 monoclonal antibody and cyclosporine A or a combination of both on chronic rejection in the rat aortic allograft model.
    Lácha J; Lehmann M; Chadimová M; Brock J; Havlícková J
    Transplant Proc; 1994 Dec; 26(6):3242-3. PubMed ID: 7998129
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.
    Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
    J Clin Invest; 1993 Aug; 92(2):549-58. PubMed ID: 8394384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine-induced endothelialitis and accelerated arteriosclerosis in chronic allograft rejection.
    Mennander A; Paavonen T; Häyry P
    Transplant Proc; 1992 Feb; 24(1):341. PubMed ID: 1539306
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic rejection after concordant xenografting.
    Scheringa M; Buchner B; Geerling RA; de Bruin RW; Schraa EO; Bouwman E; IJzermans JN; Marquet RL
    Transplant Proc; 1994 Jun; 26(3):1346-7. PubMed ID: 8029935
    [No Abstract]   [Full Text] [Related]  

  • 10. Orthotopic porcine small bowel transplantation using low-dose cyclosporine in triple immunosuppressive therapy.
    Alsina AE; Nagashima I; Schweizer RT
    Transplant Proc; 1992 Jun; 24(3):1169-71. PubMed ID: 1604573
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactivation of latent cytomegalovirus in allografts: comparison of lung graft and kidney graft in rats.
    Yagyu K; Takeshita M; Otsuka T; Kubota H; Furuse A; van Breda Vriesman PJ
    Transplant Proc; 1994 Aug; 26(4):2343-4. PubMed ID: 8066768
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine inhibits intimal hyperplasia in rat aortic allografts.
    Stoltenberg R; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
    Transplant Proc; 1994 Oct; 26(5):2569-70. PubMed ID: 7940794
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of cytomegalovirus on an experimental model of chronic renal allograft rejection under triple-drug treatment in the rat.
    Lautenschlager I; Soots A; Krogerus L; Kauppinen H; Saarinen O; Bruggeman C; Ahonen J
    Transplantation; 1997 Aug; 64(3):391-8. PubMed ID: 9275101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple-drug regimen for first kidney transplants in developing countries.
    Erken U; Erken E; Tansuğ Z; Türkyilmaz R
    Transplant Proc; 1992 Oct; 24(5):1843. PubMed ID: 1412875
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytomegalovirus infection in pediatric heart transplantation.
    Fukushima N; Gundry SR; Razzouk AJ; Bailey LL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1423-5. PubMed ID: 8382868
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat: virus-induced expression of major histocompatibility complex class II antigens.
    You XM; Steinmüller C; Wagner TO; Bruggeman CA; Haverich A; Steinhoff G
    J Heart Lung Transplant; 1996 Nov; 15(11):1108-19. PubMed ID: 8956120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide.
    Lin Y; Waer M
    Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224
    [No Abstract]   [Full Text] [Related]  

  • 18. MC1288, a vitamin D analogue, reduces short- and long-term renal allograft rejection in the rat.
    Kallio E; Häyry P; Pakkala S
    Transplant Proc; 1996 Dec; 28(6):3113. PubMed ID: 8962207
    [No Abstract]   [Full Text] [Related]  

  • 19. Rat aortic allografts: an experimental model for chronic transplant arteriosclerosis.
    Häyry P; Mennander A; Tiisala S; Halttunen J; Yilmaz S; Paavonen T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):611-2. PubMed ID: 1990624
    [No Abstract]   [Full Text] [Related]  

  • 20. Reactivation of cytomegalovirus with acute rejection and cytomegalovirus infection with obliterative bronchiolitis in rat lung allografts.
    Yagyu K; van Breda Vriesman PJ; Duijvestijn AM; Bruggeman CA; Steinhoff G
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1152-4. PubMed ID: 8382853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.